Renal protective effects and mechanisms of the angiotensin receptor-neprilysin inhibitor LCZ696 in mice with cardiorenal syndrome
Ying Li(The University of Texas at San Antonio Health Science Center), Guangping Li(Qingdao University), Kang Li(Second Hospital of Tianjin Medical University), Gary Tse(Observational & Pragmatic Research Institute), Meng Yuan(Yunnan University), Shuai Shao(Xijing Hospital), Yue Zhang, Rong Li(University of Science and Technology of China), Tong Liu(Second Hospital of Tianjin Medical University), Kai Rong(Second Hospital of Tianjin Medical University), Ya Suo(Second Hospital of Tianjin Medical University), Qiankun Bao(Second Hospital of Tianjin Medical University)
Cited by 16
Related Papers
Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation
|Journal of the American College of Cardiology|2019|494
The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy
|Nature Medicine|2016|393
Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats
|Cardiovascular Diabetology|2019|296
Association Between C-Reactive Protein and Recurrence of Atrial Fibrillation After Successful Electrical Cardioversion
|Journal of the American College of Cardiology|2007|271